Announcements Trials
Browse Landscape

Status

Completed 13Active not recruiting 6Unknown 5Recruiting 5Terminated 3Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 5Lung Neoplasms 4Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Recurrence 2Neoplasm Metastasis 2Malignant Neoplasms of Independent (Primary) Multiple Sites 2Lung Diseases 2Head and Neck Neoplasms 2cyclopia sequence 1Tobacco Use Cessation 1Smoke Inhalation Injury 1Sezary Syndrome 1Seroma 1Sarcoma 1Respiratory Aspiration 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyneuropathies 1Peripheral Nervous System Diseases 1Patient Education 1Pain 1Ovarian Neoplasms 1Occupational Stress 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1Mouth Neoplasms 1Mesothelioma 1Malignant Neoplasms of Female Genital Organs 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Carboplatin 10Paclitaxel 8Bevacizumab 7Cyclophosphamide 6olaparib 5niraparib 5Fulvestrant 4talazoparib 3Radiotherapy 3Gemcitabine 3Capecitabine 3veliparib 2palbociclib 2eribulin 2dostarlimab 2aldesleukin 2Trastuzumab 2Specimen Handling 2Letrozole 2Drug Therapy 2Doxorubicin 2Cisplatin 2Celecoxib 2Biopsy 2Albumin-Bound Paclitaxel 2tucotuzumab celmoleukin 1trastuzumab duocarmazine 1trastuzumab biosimilar HLX02 1sotigalimab 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Ovarian Neoplasms × Surveys and Questionnaires × Clear all
NCT00813254 2012-04-19

Cost Utility Analysis in Recurrent Ovarian Cancer

M.D. Anderson Cancer Center

Withdrawn
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡